YHEC attended the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress in Milan 9th -11th November 2015. Read about some of YHEC’s research presentations below.
Monday 9th November
13:15–14:15 Michelle Jenks, Matthew Taylor, Judith Shore and others estimate the cost-effectiveness of local insufflation of warm humidified CO2 during open and laparoscopic colorectal surgery compared with usual care from a UK NHS perspective.
13:15–14:15 Alex Filby, Matthew Taylor and others assess the cost-effectiveness of implementing LID-Monitor, a device to monitor levodopa-induced dyskinesia, in Parkinson’s patients.
13:15–14:15 Lindsay Claxton, Matthew Taylor, Lily Lewis and others evaluate the cost-effectiveness of edoxaban compared with warfarin for the prevention of stroke and systemic embolic events in the UK.
13:15–14:15 Lindsay Claxton, Matthew Taylor, Lily Lewis and others discusses the cost-effectiveness of edoxaban compared with other licenced NOACS for the prevention of stroke and systemic embolic events in the UK.
13:15–14:15 Matthew Taylor in collaboration with other authors discuss a new cost-effectiveness modelling approach in chronic heart failure with reduced ejection fraction.
13:15–14:15 Matthew Taylor in collaboration with other authors assess the cost-effectiveness of treatment for chronic heart failure.
18:45–19:45 William Green, Matthew Taylor and others evaluate the cost effectiveness of SQ® HDM slit-tablets in addition to pharmacotherapy compared to pharmacotherapy only in treating patients with allergic asthma.
Wednesday 11th November
12:45–13:45 Alex Filby and Matthew Taylor discuss whether QALYs are an appropriate measure to use when evaluating public health interventions in the UK and makes recommendations about the most appropriate methods to use.